Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Carcinoma, Non-Small-Cell Lung 20Prostatic Neoplasms 19Glioblastoma 18Breast Neoplasms 18Squamous Cell Carcinoma of Head and Neck 15Lung Neoplasms 12Rectal Neoplasms 11Oropharyngeal Neoplasms 10Neoplasms 9Head and Neck Neoplasms 8Glioma 8Astrocytoma 8Neoplasm Metastasis 7Sarcoma 6Esophageal Neoplasms 6Carcinoma, Squamous Cell 6Urinary Bladder Neoplasms 5Triple Negative Breast Neoplasms 5Lymphoma, Follicular 5Hodgkin Disease 5Gliosarcoma 5Esophageal Squamous Cell Carcinoma 5Carcinoma 5Burkitt Lymphoma 5Brain Neoplasms 5Adenocarcinoma of Lung 5Adenocarcinoma Of Esophagus 5Small Cell Lung Carcinoma 4Pancreatic Neoplasms 4Nasopharyngeal Carcinoma 4

Interventions

pembrolizumab 3lenvatinib 2Specimen Handling 2Nivolumab 2Cisplatin 2trastuzumab deruxtecan 1tivozanib 1liposomal doxorubicin 1entinostat 1dostarlimab 1bintrafusp alfa protein, human 1atezolizumab 1Therapeutic Touch 1Surveys and Questionnaires 1Radiotherapy 1Radiation 1Platinum 1Paclitaxel 1Nelfinavir 1Magnetic Resonance Spectroscopy 1Ipilimumab 1Gemcitabine 1Doxorubicin 1Dehydroepiandrosterone 1CTLA-4 Antigen 1Bupropion 1Blood Specimen Collection 1Bevacizumab 1Axitinib 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Vulvar Neoplasms × Radiotherapy × 90 days × Clear all
NCT04430699 2026-05-05

Cisplatin+Pembrolizumab+RT in Vulvar Cancer

Massachusetts General Hospital

Phase 2 Active not recruiting
24 enrolled
Gynecologic

Vulvar Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡